School of Medicine


Showing 3,301-3,400 of 13,056 Results

  • Margaret S. Ferris, MD

    Margaret S. Ferris, MD

    Clinical Assistant Professor, Adult Neurology
    Clinical Assistant Professor (By courtesy), Neurosurgery

    BioDr. Ferris is a fellowship-trained neurologist and Clinical Assistant Professor in the Department of Neurology, Division of Movement Disorders.

    She diagnoses and treats a breath of movement disorders such as Parkinson’s disease and essential tremor. She recognizes the broad effects of these conditions on daily living and aims to develop personalized, comprehensive treatment plans that optimize health and quality of life.

    Dr. Ferris research interests focus on access to interventional therapies for movement disorders. She has participated in investigations sponsored by the National Institutes of to evaluate advanced treatments for complications of Parkinson’s disease.

    She has co-authored articles in publications such as Nature, The Neurohospitalist, and BioMed Central (BMC) Genomics. She has presented her insights about innovations in the understanding, detection, and management of movement disorders at conferences including, the Society for Neuroscience Annual Meeting, Pan American Parkinson’s Disease and Movement Disorders Congress.

    She is a member of the American Academy of Neurology and the Movement Disorder Society.

    Essential tremor patient story: https://www.youtube.com/watch?v=fV6BzyU9b3c

  • Nicolas Fesser

    Nicolas Fesser

    Clinical Instructor, Emergency Medicine

    BioNico Fesser, MD, is a Global Emergency Medicine Fellow in the Department of Emergency Medicine at Stanford University and a Stanford Global Health Postdoctoral Affiliate with the Center for Innovation in Global Health (CIGH), Stanford's university-wide hub for global health research, education, and training. He completed his residency in Emergency Medicine at the University of Washington, where he received the Resident Peer Recognition Award and the UW Medical Center Martin Luther King Jr. Community Service Award. He earned his MD from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, where he was elected to Alpha Omega Alpha and the Gold Humanism Honor Society and received the Medical Alumni Association Award. He completed his undergraduate studies in Neurobiology, with a minor in Global Health, at the University of Wisconsin–Madison. Born and raised in Madrid, he moved to upstate New York at age fourteen.

    Dr. Fesser's interests include global emergency care, humanitarian response, and resource mobilization, particularly within conflict-affected settings. He has worked and collaborated directly within this context with organizations such as the United Nations, the West Africa AIDS Foundation, and Partners In Health. He has also conducted public health projects and worked clinically across much of sub-Saharan Africa, including Ebola response in the Democratic Republic of the Congo (DRC), tuberculosis care in Lesotho, and HIV/AIDS work in Ghana and Tanzania, among others.

    A central focus of his work is the rescue, demobilization, and reintegration of children affected by armed conflict in the eastern DRC. In 2020, he founded Fesser and Friends, a nonprofit organization that operates two child rescue and rehabilitation centers in the province of North Kivu and serves as UNICEF's referral center of choice in the region. The center in Beni serves children orphaned by armed conflict, many of them survivors of some of the country's worst mass atrocities. The center in Goma supports the long-term demobilization and reintegration of former child soldiers, many of whom were forced to commit acts of violence themselves. Both provide housing, medical care, education, vocational training, and family reunification services. To date, the organization has reunited hundreds of missing children with their families and has provided over a quarter of a million meals to children and displaced families. He also founded Beyond the Rhythm, a music-based fundraising initiative that helps support some of this work.

    His fellowship training combines clinical practice with targeted coursework in tropical medicine, humanitarian operations, nonprofit leadership, and diplomacy. He is currently completing the Diploma in Tropical Medicine and Hygiene at the London School of Hygiene & Tropical Medicine. His planned coursework also includes the Executive Program for Nonprofit Leaders at the Stanford Graduate School of Business and the Health Emergencies in Large Populations (HELP) course at the University of Geneva, developed with the ICRC and WHO. In his second year, he will complete the Certificate in International Relations and Diplomacy at Sciences Po in Paris.

    Dr. Fesser works at the intersection of emergency medicine, humanitarian diplomacy, and policy to improve outcomes for children and communities affected by armed conflict. Following his fellowship, he aspires to serve in senior leadership roles within humanitarian and governmental organizations.

  • Dorien Feyaerts

    Dorien Feyaerts

    Instructor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsBiomedical scientist and immunologist with a strong background in fetal-maternal immunology that aims to conduct impactful translational research in women’s health to improve the health of mothers and their children.

  • Priya Fielding-Singh

    Priya Fielding-Singh

    Postdoctoral Scholar, SCRDP/ Heart Disease Prevention

    BioI am a Sociologist and Postdoctoral Fellow in Cardiovascular Disease Prevention at the Stanford Prevention Research Center. My research examines health, gender, and social inequality.

    My primary research agenda investigates health disparities across class, race, and gender in the United States. I draw on both qualitative and quantitative methods to understand how neighborhoods, schools, and families shape our health behaviors and outcomes. My work has been published in journals such as Social Science & Medicine, Obesity, Sociological Science, and the Journal of Adolescent Health.

    I hold a Ph.D. in Sociology from Stanford University, a M.A. in Anthropology from the University of Bremen, and a B.S. in Education and Social Policy from Northwestern University.

  • Vikram Fielding-Singh, MD, JD

    Vikram Fielding-Singh, MD, JD

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsImproving perioperative care of patients with end stage kidney disease, using biomarkers to aid early diagnosis of acute kidney injury, and evaluating the performance of risk prediction models in perioperative medicine.

  • Caroline Figueroa, MD PhD

    Caroline Figueroa, MD PhD

    Visiting Scholar, Pediatrics - General Pediatrics

    BioCaroline Figueroa, MD, PhD, is a visiting scholar at Stanford University. She is the 2025–26 Dutch Commonwealth Fund Harkness Fellow in Health Care Policy and Practice. She is an assistant professor at Delft University of Technology (TU Delft) in the Netherlands, where she leads the Research on Inclusive Solutions and Empowerment in Digital Health (RISE) group. Her work focuses on making digital mental health solutions — such as apps and AI-chatbots — safe, effective, and accessible, particularly for adolescents, young adults, and women. Figueroa’s research on digital health equity has directly informed policy documents by global organizations such as the World Health Organization and the United Nations, and has been published in leading journals including Lancet Digital Health, Journal of the American Medical Informatics Association, and Human Brain Mapping.

    Figueroa is a medical doctor with a PhD in the neuroscience of depression from the University of Amsterdam and the University of Oxford; she also has several years of experience in clinical psychiatry. Before joining TU Delft, she was a postdoctoral scholar at the University of California, Berkeley.

  • Marcos Figueroa

    Marcos Figueroa

    Access Service Specialist, School of Medicine - Lane Medical Library

    Current Role at StanfordStanford University - School of Medicine - Lane Medical Library
    Library Specialist-Circulation Evening Supervisor; Bills & Fines Coordinator

  • Andrey Finegersh, MD, PhD

    Andrey Finegersh, MD, PhD

    Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)

    BioDr. Finegersh is a fellowship-trained head and neck surgical oncologist with board certification in otolaryngology and an Assistant Professor with the Stanford School of Medicine Department of Otolaryngology.

    He specializes in treatment of benign and malignant tumors of the head and neck and has received additional training in microvascular reconstruction and transoral robotic surgery. He takes tremendous pride in providing compassionate care for patients and managing challenging diagnoses.

    Dr. Finegersh completed his MD and PhD degrees at the University of Pittsburgh School of Medicine's combined Medical Scientist Training Program. He went on to complete residency in otolaryngology at the University of California San Diego (UCSD) and his fellowship at Stanford University, where he stayed on as faculty.

    He has extensive research experience in head and neck cancer epigenetics and completed post-doctoral research at the University of Pittsburgh and UCSD. He has received grants from the NIH and American Academy of Otolaryngology and has an active research lab studying molecular mechanisms of cancer. Dr. Finegersh has additional clinical interests in studying the role of minimally invasive surgery to improve outcomes for head and neck cancer patients.

  • Anna Finley Caulfield, MD

    Anna Finley Caulfield, MD

    Clinical Professor, Adult Neurology

    Current Research and Scholarly InterestsDr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.

  • David Fiorentino, MD, PhD

    David Fiorentino, MD, PhD

    Professor of Dermatology

    Current Research and Scholarly InterestsFrom a clinical standpoint, I am particularly focused in the care of patients with myositis or systemic sclerosis. We offer clinical trials, including novel, cutting-edge cellular-based (e.g. chimeric antigen receptor, or, CAR T) therapies for these diseases. We are particularly interested in understanding the role of auto antigens in providing windows into disease pathogenesis, as well as their potential direct role of autoantibodies in causing disease.

  • Kyla Lynne Fiorey

    Kyla Lynne Fiorey

    Life Science Research Professional 1, Urology - Divisions

    Current Role at StanfordLife Science Research Professional

  • Andrew Fire

    Andrew Fire

    George D. Smith Professor of Molecular and Genetic Medicine and Professor of Pathology and of Genetics

    Current Research and Scholarly InterestsWhile chromosomal inheritance provides cells with one means for keeping and transmitting genetic information, numerous other mechanisms have (and remain to be) discovered. We study novel cellular mechanisms that enforce genetic constancy and permit genetic change. Underlying our studies are questions of the diversity of inheritance mechanisms, how cells distinguish such mechanisms as "wanted" versus "unwanted", and of the consequences and applications of such mechanisms in health and disease.

  • Daniel James Firl

    Daniel James Firl

    Clinical Instructor, Surgery - Abdominal Transplantation

    BioDaniel Firl is an abdominal transplant surgery fellow at Stanford Medicine and a surgeon-scientist working at the intersection of hepatobiliary cancer surgery and transplantation. His work centers on patient selection in primary liver cancer — determining which patients are best served by resection and which by transplantation — and on the risk-assessment tools that make that decision more precise.

    He is a co-developer of HALT-HCC, a risk model for liver transplantation in hepatocellular carcinoma, and first author of its international validation across more than 4,000 patients. His aim is to make selection between resection and transplantation progressively more sophisticated — sharpening prediction of waitlist and post-transplant outcomes, informing donor selection, and enabling the safe use of grafts that might otherwise be declined — with a particular interest in intrahepatic cholangiocarcinoma and gallbladder cancer, where the role of transplantation is still being defined. He sees the next step as the integration of tumor genomics, bringing the molecular features of each cancer into the models that guide surgical decisions.

    Earlier, during postdoctoral training at the Massachusetts General Hospital, he studied the immunology and physiology of kidney xenotransplantation, including the design and long-term function of organs from genetically engineered porcine donors — part of the broader effort to expand the supply of transplantable organs.

    Dr. Firl completed general surgery residency at Duke University, where he served as chief resident, and earned his MD with Special Qualifications in Biomedical Research through the research-intensive program at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He holds a bachelor's degree in biochemistry from Boston College.

    He is the author of over 30 peer-reviewed articles, with work in Nature, Cell, The Lancet Gastroenterology & Hepatology, Hepatology, and The Lancet Digital Health. He serves as an ad hoc reviewer for journals including The BMJ, Kidney International, the American Journal of Transplantation, JCO Precision Oncology, and Transplantation.

    He has received fellowships and grant funding from prestigious organizations during competitive funding opportunities including from: the NIH-NIAID, Howard Hughes Medical Institute, and the American Society of Transplantation.

  • Michael Fischbach

    Michael Fischbach

    Liu (Liao) Family Professor

    Current Research and Scholarly InterestsThe microbiome carries out extraordinary feats of biology: it produces hundreds of molecules, many of which impact host physiology; modulates immune function potently and specifically; self-organizes biogeographically; and exhibits profound stability in the face of perturbations. Our lab studies the mechanisms of microbiome-host interactions. Our approach is based on two technologies we recently developed: a complex (119-member) defined gut community that serves as an analytically manageable but biologically relevant system for experimentation, and new genetic systems for common species from the microbiome. Using these systems, we investigate mechanisms at the community level and the strain level.

    1) Community-level mechanisms. A typical gut microbiome consists of 200-250 bacterial species that span >6 orders of magnitude in relative abundance. As a system, these bacteria carry out extraordinary feats of metabolite consumption and production, elicit a variety of specific immune cell populations, self-organize geographically and metabolically, and exhibit profound resilience against a wide range of perturbations. Yet remarkably little is known about how the community functions as a system. We are exploring this by asking two broad questions: How do groups of organisms work together to influence immune function? What are the mechanisms that govern metabolism and ecology at the 100+ strain scale? Our goal is to learn rules that will enable us to design communities that solve specific therapeutic problems.

    2) Strain-level mechanisms. Even though gut and skin colonists live in communities, individual strains can have an extraordinary impact on host biology. We focus on two broad (and partially overlapping) categories:

    Immune modulation: Can we redirect colonist-specific T cells against an antigen of interest by expressing it on the surface of a bacterium? How do skin colonists induce high levels of Staphylococcus-specific antibodies in mice and humans?

    Abundant microbiome-derived molecules: By constructing single-strain/single-gene knockouts in a complex defined community, we will ask: What are the effects of bacterially produced molecules on host metabolism and immunology? Can the molecular output of low-abundance organisms impact host physiology?

    3) Cell and gene therapy. We have begun two new efforts in mammalian cell and gene therapies. First, we are developing methods that enable cell-type specific delivery of genome editing payloads in vivo. We are especially interested in delivery vehicles that are customizable and easy to manufacture. Second, we have begun a comprehensive genome mining effort with an emphasis on understudied or entirely novel enzyme systems with utility in mammalian genome editing.

  • Michael Fischbein

    Michael Fischbein

    Thelma and Henry Doelger Professor of Cardiovascular Surgery

    Current Research and Scholarly InterestsMolecular and genetic mechanisms of aortic aneurysm/dissection development. Molecular mechanisms of aneurysm formation in Marfan Syndrome. Clinical research interests include thoracic aortic diseases (aneurysms, dissections).

  • Adina S. Fischer, MD, PhD

    Adina S. Fischer, MD, PhD


    BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.

    Dr. Fischer’s translational program of research focuses on:
    (1) Improving our understanding of protective biomarkers of resilience to depression
    (2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
    (3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use

    Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences.

  • Avital Sabrina Fischer

    Avital Sabrina Fischer

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioAvital Fischer’s work focuses on the relationship between stress and wellbeing. She has expertise in women’s mental health, physician wellbeing, post-traumatic stress disorder, and other stress-related disorders. Her current research focuses on the impact of war-related stress on partners of reservists in Israel. The Invisible Warriors Study is a longitudinal prospective study following nearly 400 women to examine predictors of wellbeing under chronic stress in Israel. She is particularly interested in interventions that focus on the partner as the primary attachment figure of the reservist and their potential to improve PTSD outcomes for both members of the dyad. She has experience working with patients with PTSD related to a range of traumatic experiences, with particular expertise in war- and terror-related trauma through her clinical work with this population at Sheba Medical Center in Israel.

    Avital is also an advocate for physician wellbeing and for supporting successful and fulfilling careers in medicine while reducing burnout. She is particularly interested in how to sustain self-compassion and interpersonal relationships during medical training, promote a culture of wellness at the institutional level, and address the specific challenges faced by women in medicine. She has worked with Stanford residents, fellows, graduate students, and postdoctoral scholars through her clinical work and her experience as a Women in Science and Engineering (WISE) facilitator.

  • Nico Fischer

    Nico Fischer

    Affiliate, Psych/Public Mental Health & Population Sciences

    Bio2022-2026 Santa Clara High School
    Advisor, Stanford Center for Youth Mental Health and Wellbeing
    Chair, County of Santa Clara Youth Task Force

  • Kevin Fish

    Kevin Fish

    Professor of Anesthesia at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsNeurological dysfunction after cardiopulmonary bypass;, metabolism of inhalation anesthetics.

  • Ann Caroline Fisher, MD

    Ann Caroline Fisher, MD

    Clinical Professor, Ophthalmology

    BioCaroline Fisher, MD, is a Clinical Professor of Ophthalmology at Stanford University Hospital and Clinics. She specializes in cataract and glaucoma surgery, including minimally invasive glaucoma surgery.

    She completed her undergraduate education at Stanford University, obtaining both a Bachelor of Science degree in Biology and a Bachelor of Arts degree in Spanish, with Departmental Honors. She earned her medical degree from Stanford University School of Medicine and then went on to her internship at the University of Pennsylvania Presbyterian Hospital. She completed her ophthalmology residency at NYU/ Manhattan Eye, Ear, Throat Hospital. She then returned to Stanford for her Glaucoma Fellowship.

    Dr. Fisher is Director of the Stanford Belize Vision Clinic, dedicated to promoting eye health and care in Belize, and providing an international rotation for Stanford Ophthalmology Residents. She is also an Office of Faculty Development and Engagement Liaison and is currently one of the Stanford Network for Advancement and Promotion (SNAP) Cohort Leaders. Dr. Fisher is the Director of Development and Engagement for the Department of Ophthalmology.

  • George A. Fisher Jr.

    George A. Fisher Jr.

    Colleen Haas Chair in the School of Medicine, Emeritus

    Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.

  • Paul Graham Fisher, MD

    Paul Graham Fisher, MD

    Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health

    Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.

  • Philip Andrew Fisher

    Philip Andrew Fisher

    Diana Chen Professor of Early Childhood Learning and Professor, by courtesy, of Pediatrics

    BioDr. Philip Fisher is the Diana Chen Professor of Early Childhood Learning in the Graduate School of Education and the Director of the Stanford Center on Early Childhood. His research, focuses on developing and evaluating scalable early childhood interventions in communities, and on translating scientific knowledge regarding healthy development under conditions of adversity for use in social policy and programs. He is particularly interested in the effects of early stressful experiences on children's development, and in prevention and treatment programs for improving children's functioning in areas such as relationships with caregivers and peers, social-emotional development, and academic achievement. He is currently the lead investigator in the ongoing RAPID-EC project, a national survey on the well-being of households with young children during the COVID-19 pandemic. Dr. Fisher is the developer of a number of widely implemented evidence-based interventions for supporting healthy child development in the context of social and economic adversity, including Treatment Foster Care Oregon for Preschoolers (TFCO-P) and Kids in Transition to School (KITS). Most recently, he developed the Filming Interactions to Nurture Development (FIND) video coaching program for supporting parenting in the home environment and early childhood care and education professionals in childcare and preschool contexts. He has published over 250 scientific papers in peer reviewed journals. He is the recipient of the 2012 Society for Prevention Research Translational Science Award, and a 2019 Fellow of the American Psychological Society.

  • Robert Fisher, MD, PhD

    Robert Fisher, MD, PhD

    The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.

  • Daniel Owen Fishman

    Daniel Owen Fishman

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
    Clinical Assistant Professor (By courtesy), Medicine - Blood & Marrow Transplantation

    BioAfter graduating from Vanderbilt Medical School, Dr. Fishman completed the Psychiatry Residency Program at University of Pittsburgh Medical Center, where he served as Chief Resident and was lauded with the program’s sole Teaching Award. Thereafter, Dr. Fishman completed the Consultation-Liaison Psychiatry Fellowship also at the University of Pittsburgh Medical Center. During his training, he also served as Chief Fellow was elected into Alpha Omega Alpha, Honors Medical Society. In the subsequent years, Dr. Fishman practiced as a consultation and liaison psychiatrist, simultaneously serving both academic and community hospitals in the Greater Pittsburgh Area. In his outpatient clinic, he managed and treated patients with complex issues linking the domains of neurology and psychiatry, and specialized in nonepileptic episodes.

    Dr. Fishman joined the faculty of Stanford University School of Medicine in 2020 as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since his appointment, Dr. Fishman has led medical psychiatry services on the medical/surgical units, intensive care units and in the emergency department at Stanford Hospital to provide psychiatric care for patients with acute diagnoses and provide graduate medical education to psychiatry, internal medicine, palliative care, oncology, and neurology trainees. His work on developing a framework for evidence-based best practice guidelines was recognized with a 2020 DLIN/Fischer finalist award.

    Dr. Fishman is the appointed Chief of the Inpatient Proactive Psycho-Oncology Service, a service designed to proactively identify patients with psychopathology or who will require psychiatric intervention during their hospitalization. The service helps prevent development and escalation of psychopathology in the inpatient blood and marrow transplant and other cancer populations. His outpatient work is primarily as a psychiatric oncologist at the Stanford Cancer Center where he provides psychiatric consultation services and collaborates closely with his oncology colleagues to deliver comprehensive cancer care.

    His clinical and scholarly interests include the interface of medicine and psychiatry, psycho-oncology, catatonia, neuropsychiatry, collaborative care models, psychotherapy for the medically ill, interdisciplinary and graduate medical education.

  • Jack Fitzgerald

    Jack Fitzgerald

    Postdoctoral Scholar, SCRDP/ Heart Disease Prevention

    Current Research and Scholarly InterestsI work on issues in applied econometrics, replication, and metascience, and I am dedicated to improving methods in scientific research. I specifically work on replication-based methods research, equivalence testing and practical significance testing, robustness tests for causal inference, and replication.

  • Matthew Fitzgerald, PhD

    Matthew Fitzgerald, PhD

    Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS)

    Current Research and Scholarly InterestsMy research encompasses several translational projects. One focus is to modify the routine audiologic test battery such that it places equal weight on hearing acuity and hearing function. This work includes measures of speech in noise, or electrophysiologic responses such as the FFR. I also explore tools to better assess and maximize performance in users of hearing aids and cochlear implants. Finally, I am also investigating the benefits of telemedicine, and new treatments for tinnitus.

  • Peter Fitzgerald, MD, PhD

    Peter Fitzgerald, MD, PhD

    Professor (Research) of Medicine (Cardiovascular), Emeritus

    BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University School of Medicine. He is an interventional cardiologist and holds a PhD in engineering. He is a professor in both the Department of Medicine and the Department of Engineering (by courtesy) at Stanford.

    Dr. Fitzgerald has led or participated in more than 175 clinical trials, has published more than 550 manuscripts and book chapters, and lectures worldwide. Over the past two decades, he has trained more than 150 postdoctoral researchers in engineering and medicine. Most recently, Dr. Fitzgerald completed two years of study toward a master’s degree focused on machine learning and agentic principles supporting AI.

    Dr. Fitzgerald has been a principal founder of 24 medical startups in the San Francisco Bay Area and has transitioned 17 of them to large medical device companies. He serves on several boards of directors and advises dozens of medical device startups, as well as multinational healthcare companies, on the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Dr. Fitzgerald was part of the founding team of LVP Capital, a venture firm focused on medical device and biotechnology startups in San Francisco. In 2010, he co-founded Triventures, an early-stage medical technology fund with offices in Palo Alto and Tel Aviv.

  • Caroline Fleck

    Caroline Fleck

    Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences

    BioDr. Caroline Fleck received her doctorate in Psychology & Neuroscience from Duke University, and went on to specialize in cognitive behavioral therapies including Exposure and Response Prevention, Dialectical Behavior Therapy, Parent Management Training, Gottman Method Couples Therapy, and Behavioral Activation. She is the founder and clinical director of Luma - a network of evidence-based clinicians in private practice. Dr. Fleck is also a trainer, educator, and public speaker on the topics of evidence-based approaches in psychology, mindfulness, and the use of technology in mental health care. Her lectures and courses at Stanford focus on training residents, post-docs, and faculty in Dialectical Behavior Therapy, and risk management.

    More information can be found on her website: https://www.drcarolinefleck.com/

  • Ross Fleischman

    Ross Fleischman

    Clinical Professor, Emergency Medicine

    BioRoss joined the Department of Emergency Medicine in September as a Clinical Professor. He was previously at Harbor-UCLA Medical Center and the UCLA David Geffen School of Medicine, bringing extensive experience in electronic health record implementation, research informatics, wilderness medicine, and disaster preparedness and response. His academic interests include cancer emergencies, the use of electronic health record data for research, and advancing research by medical students, residents, and fellows.

  • Dominik Fleischmann

    Dominik Fleischmann

    Professor of Radiology (Cardiovascular Imaging)

    Current Research and Scholarly InterestsNon-invasive Cardiovascular Imaging
    Image Post-processing
    Contrast Medium Dynamics

  • Barry Fleisher

    Barry Fleisher

    Associate Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus

    Current Research and Scholarly InterestsNeonatology, neurobehavioral development, outcomes in premature infants.

  • Annesa Flentje

    Annesa Flentje

    Professor (Research) of Medicine (Stanford Prevention Research Center)

    BioAnnesa Flentje, PhD, is a Professor at Stanford University in the Stanford Prevention Research Center, Department of Medicine, School of Medicine. Dr. Flentje is a clinical psychologist who uses multiple methods to understand the impacts of stress and coping on human health and disease. Her research has investigated how stress directly impacts health outcomes and how these processes are mediated through both behaviors (e.g., substance use and coping) and molecular mechanisms (e.g., epigenetics and transcriptional regulation). Dr. Flentje has developed cognitive behavioral interventions to reduce stress, and identified these as a mechanism to alter immune pathways in gene expression. Dr. Flentje is currently leading a large comparative effectiveness study of two interventions for posttraumatic stress symptoms among LGBTQIA+ populations in California. Dr. Flentje has developed and led nationwide mentoring initiatives to support health research of understudied populations and translational research to improve health. Dr. Flentje is Co-Director of The PRIDE Study (pridestudy.org), a national longitudinal cohort study of LGBTQIA+ individuals within the United States that has enrolled over 30,000 participants and is approaching 10 years of data collection.

  • Pamela Flood

    Pamela Flood

    Adjunct Clinical Professor, Anesthesiology, Perioperative and Pain Medicine

    BioDr. Flood is a Professor at Stanford University who is fellowship trained in Pain Medicine and Obstetric Anesthesiology. She specializes in the treatment of chronic pelvic pain and multiple aspects of women's health including the prevention of chronic pain after childbirth. Research interests include the role of multimodal treatment in chronic pain conditions and prevention of persistent opioid use. Her research has spanned from detailed pharmacodynamic analysis, clinical trials to population health.

  • Lara Foland-Ross

    Lara Foland-Ross

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioI am a neuroscientist and Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University, where I serve as Associate Director of Precision Mental Health Research Programs in the Stanford Center for Precision Mental Health (CPMH). My research uses neuroimaging, cognitive, and behavioral approaches to understand individual differences in the brain systems underlying mood and cognition, with the goal of translating these differences into more precise approaches to mental health care.

    A central focus of my work is understanding how individual brain and behavioral patterns can inform prognosis and treatment selection for depression. Currently, I serve as Scientific Director and Co-Investigator of ACE-D (“Accelerating Cognition-guided signatures to Enhance translation in Depression”), a large NIH-funded study testing cognition-guided precision approaches to depression treatment.

    I also serve as Scientific Program Lead and a Commissioner for the Nature Mental Health Precision Mental Health Commission, an international initiative working to define the field of precision mental health and accelerate the translation of its strongest science into meaningful clinical use.

    Across these roles, I am particularly interested in bridging scientific discovery and clinical application—identifying where current approaches fall short, asking questions that can change how we understand mental health, and helping build practical paths from research findings to better decisions and outcomes for patients.

  • Ann Folkins

    Ann Folkins

    Associate Professor of Pathology

    Current Research and Scholarly InterestsDr. Folkins' interest is in gynecologic and obstetric pathology, specifically in ovarian and endometrial malignancies and placental clinical-pathologic disorders.

  • Sai Folmsbee, MD, PhD

    Sai Folmsbee, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsMy current research interest is the intersection of psychiatry and neuroimmunology. I am currently collaborating with Stanford Neuroimmunology in a retrospective analysis of patient data to determine the relationship between psychaitric medications and clinical outcomes in hospitalized patients with mutliple sclerosis, autoimmune encephalitis, and neuromyelitis optica.

  • Eric Foote

    Eric Foote

    Clinical Assistant Professor, Pediatrics - Neonatology

    BioEric Foote is a pediatric hospitalist with experience conducting clinical and public health research around the world. His research focuses on identifying and intervening on health disparities in low income countries and in low resource settings. Currently, he is developing and evaluating a community health worker-led household phototherapy intervention to extend access to neonatal jaundice care for newborns in rural Bangladesh. He is also working to improve SARS-CoV-2 testing and genomic surveillance across California and worldwide.

  • James Ford

    James Ford

    Professor of Medicine (Oncology) of Genetics and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsMammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA damage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.

  • Judith Ford

    Judith Ford

    Professor (Research) of Psychiatry and Behavioral Sciences, Emeritus

    Current Research and Scholarly InterestsWe are using functional brain imaging methods (electrophysiology and magnetic resonance imaging) to study symptoms of schizophrenia such as auditory hallucinations, self-monitoring failures, emotional blunting, and cognitive deficits.

  • Polly Fordyce

    Polly Fordyce

    Associate Professor of Bioengineering and of Genetics

    Current Research and Scholarly InterestsThe Fordyce Lab is focused on developing new instrumentation and assays for making quantitative, systems-scale biophysical measurements of molecular interactions. Current research in the lab is focused on three main platforms: (1) arrays of valved reaction chambers for high-throughput protein expression and characterization, (2) spectrally encoded beads for multiplexed bioassays, and (3) sortable droplets and microwells for single-cell assays.

  • Daiana Fornes

    Daiana Fornes

    Life Science Research Professional 3, Obstetrics Anesthesiology

    BioDaiana Fornes is a postdoctoral scholar at Stanford University, supported by a Maternal & Child Health Research Institute (MCHRI) Postdoctoral Fellowship. Her research centers on reproductive biology and pregnancy disorders, with a particular focus on uterine contractility, preterm labor, and uterine atony. She investigates calcium signaling pathways, including the role of TRPV4 ion channels, to identify novel therapeutic strategies aimed at improving maternal health outcomes.

    Daiana earned her PhD from the University of Buenos Aires, where she studied metabolic alterations during pregnancy and their effects on fetal development. Her training has provided her with a strong foundation in translational research, with extensive experience in experimental design, molecular biology, and the analysis of signaling pathways.